KEGG   DRUG: Brivekimig
Entry
D13138                      Drug                                   
Name
Brivekimig (USAN/INN)
Sequence
DVQLVESGGG VVQPGGSLRL SCAASGRTFS SIYAKGWFRQ APGKEREFVA AISRSGRSTS
YADSVKGRFT ISRDNSKNTV YLQMNSLRPE DTALYYCAAV GGATTVTASE WDYWGQGTLV
TVSSGGGGSG GGSEVQLVES GGGVVQPGGS LRLSCAASGR TFSSIYAKGW FRQAPGKERE
FVAAISRSGR STSYADSVKG RFTISRDNSK NTVYLQMNSL RPEDTALYYC AAVGGATTVT
ASEWDYWGQG TLVTVSSGGG GSGGGSEVQL VESGGGVVQP GGSLRLSCAA SGFTFSDYWM
YWVRQAPGKG LEWVSEINTN GLITKYPDSV KGRFTISRDN AKNTLYLQMN SLRPEDTALY
YCARSPSGFN RGQGTLVTVS SGGGGSGGGS EVQLVESGGG VVQPGGSLRL SCAASGFTFR
SFGMSWVRQA PGKGPEWVSS ISGSGSDTLY ADSVKGRFTI SRDNSKNTLY LQMNSLRPED
TALYYCTIGG SLSRSSQGTL VTVSSGGGGS GGGSEVQLVE SGGGVVQPGG SLRLSCAASG
FTFSDYWMYW VRQAPGKGLE WVSEINTNGL ITKYPDSVKG RFTISRDNAK NTLYLQMNSL
RPEDTALYYC ARSPSGFNRG QGTLVKVSSA
(Disulfide bridge: 22-97, 155-230, 288-362, 412-486, 536-610)
  Type
Peptide
Efficacy
Anti-inflammatory
  Type
Bispecific antibody
Comment
Treatment of hidradenitis suppurativa
Target
TNFSF4 (CD252, OX40L) [HSA:7292] [KO:K05469]
TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Tumor necrosis factors
    TNF (TNFA, TNFSF2)
     D13138  Brivekimig (USAN/INN)
Other DBs
CAS: 2834733-45-6
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system